A Time-Series Metabolomic Analysis of SARS-CoV-2 Infection in a Ferret Model

Karpe, Avinash V.; Nguyen, Thao V.; Shah, Rohan; Au, Gough G.; McAuley, Alexander J.; Marsh, Glenn A.; Riddell, Sarah; Vasan, Seshadri S.; Beale, David J.

doi:10.3390/metabo12111151

Cited by 1 publication

(1 citation statement)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The integration not only indicated the key microbiome species impacted, but it also helped to filter the most significant redox pathways impacting the gut–liver axis. Similar strategies have been further employed to understand the extra-gut mechanism of FGIDs, such as IBS, functional dyspepsia [ 124 ], and infections such as SARS-CoV2 [ 125 , 126 ]. In the area of the nutritional impacts of prebiotics and probiotics, the study reported by Shinde, et al [ 64 ] included the combined approach of immunohistochemistry, enzyme kinetics, and metabolomics, including SCFA analytics.…”

Section: Application Of Multiomics In High-throughput Analysis Of Gut...mentioning

confidence: 99%

Intelligent Biological Networks: Improving Anti-Microbial Resistance Resilience through Nutritional Interventions to Understand Protozoal Gut Infections

2023

Self Cite

View full text Add to dashboard Cite

Enteric protozoan pathogenic infections significantly contribute to the global burden of gastrointestinal illnesses. Their occurrence is considerable within remote and indigenous communities and regions due to reduced access to clean water and adequate sanitation. The robustness of these pathogens leads to a requirement of harsh treatment methods, such as medicinal drugs or antibiotics. However, in addition to protozoal infection itself, these treatments impact the gut microbiome and create dysbiosis. This often leads to opportunistic pathogen invasion, anti-microbial resistance, or functional gastrointestinal disorders, such as irritable bowel syndrome. Moreover, these impacts do not remain confined to the gut and are reflected across the gut–brain, gut–liver, and gut–lung axes, among others. Therefore, apart from medicinal treatment, nutritional supplementation is also a key aspect of providing recovery from this dysbiosis. Future proteins, prebiotics, probiotics, synbiotics, and food formulations offer a good solution to remedy this dysbiosis. Furthermore, nutritional supplementation also helps to build resilience against opportunistic pathogens and potential future infections and disorders that may arise due to the dysbiosis. Systems biology techniques have shown to be highly effective tools to understand the biochemistry of these processes. Systems biology techniques characterize the fundamental host–pathogen interaction biochemical pathways at various infection and recovery stages. This same mechanism also allows the impact of the abovementioned treatment methods of gut microbiome remediation to be tracked. This manuscript discusses system biology approaches, analytical techniques, and interaction and association networks, to understand (1) infection mechanisms and current global status; (2) cross-organ impacts of dysbiosis, particularly within the gut–liver and gut–lung axes; and (3) nutritional interventions. This study highlights the impact of anti-microbial resistance and multi-drug resistance from the perspective of protozoal infections. It also highlights the role of nutritional interventions to add resilience against the chronic problems caused by these phenomena.

show abstract